Manuscripts
Showing 1595 manuscripts.
Serologic Examination of Hepatitis B Infection and Immunization in HIV-Positive Youth and Associated Risks.
Citation
Adrienne Rogers, M.D., Jane C. Lindsey, Sc.D., Donna Futterman, M.D., Bonnie Zimmer, B.S., Susan Abdalian, M.D., Lawrence D'Angelo, M.D., M.P.H. Serologic Examination of Hepatitis B Infection and Immunization in HIV-Positive Youth and Associated Risks. AIDS. 2002 Jul 16; 14(12):651-657.Year
2002
Journal
AIDS
Analysis of HIV-1 Drug Resistance in Children Receiving Nucleoside Analog Reverse Transcriptase Inhibitors Plus Nevirapine, Nelfinavir or Ritonavir.
Citation
Susan H. Eshleman, M.D., PH.D., Paul Krogstad, M.D., Brooks Jackson, M.D., M.B.A., YouGan Wang, Sabina Lee, Lee-Jen Wei, Ph.D., Coleen K. Cunningham, M.D., Michael Wantman, Andrew A. Wiznia, M.D., George M. Johnson, M.D., Sharon Appelbaum Nachman, M.D., Paul Palumbo, M.D. Analysis of HIV-1 Drug Resistance in Children Receiving Nucleoside Analog Reverse Transcriptase Inhibitors Plus Nevirapine, Nelfinavir or Ritonavir. Journal of Infectious Diseases. 2002 Jul 17; 1732-1708.Year
2002
Journal
Journal of Infectious Diseases
Vertical transmission of Subtype D and Subtype A/G Human Immunodeficiency virus in the United States.
Citation
Paul Krogstad, M.D., Susan H. Eshleman, M.D., PH.D., Jennifer Jackson, Michael Wantman, Bette T. Korber, Andrew A. Wiznia, M.D., George M. Johnson, M.D., Sharon Appelbaum Nachman, M.D., Paul Palumbo, M.D. Vertical transmission of Subtype D and Subtype A/G Human Immunodeficiency virus in the United States. AIDS Research and Human Retroviruses. 2002 Aug 31; 18:413-417.Year
2002
Journal
AIDS Research and Human Retroviruses
Development of resistence mutations in women receiving standard antiretrovial therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of Pediatric AIDS Clinical Trials Group P316.
Citation
Coleen Cunningham, M.D., Marie-Laure Chaix, Claire Rekacewicz, M.D., Paula Britto, M.S., Christine Rouzioux, Ph.D., Richard D. Gelber, Ph.D., Alejandro Dorenbaum, M.D., Jean-Francois Delfraissy, M.D., B. Brazin, Lynne M. Mofenson, M.D., F.A.A.P., John L. Sullivan, M.D., John P. Sullivan, M.D. Development of resistence mutations in women receiving standard antiretrovial therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of Pediatric AIDS Clinical Trials Group P316. Journal of Infectious Diseases. 2002 Dec 17; 186(2):181-8.Year
2002
Journal
Journal of Infectious Diseases
Persistent HIV-1 DNA in PBNC of Children on HIghlyActive Antiretroviral Therapy Despite Prolonged Suppression of Plasma HIV-1 RNA.
Citation
A. Saitoh, Terence Fenton, Ed.D., Karen Hsia, Ph.D., Christine Powell, M.A., Cindy Christopherson, Courtney V. Fletcher, Pharm.D., Stuart E. Starr, M.D., Stephen A. Spector, M.D. Persistent HIV-1 DNA in PBNC of Children on HIghlyActive Antiretroviral Therapy Despite Prolonged Suppression of Plasma HIV-1 RNA. Journal of Infectious Diseases. 2002 May 15; 185(10):1409-16.Year
2002
Journal
Journal of Infectious Diseases
Lack of improvement in growth in HIV-infected children receiving ritonavir-containing highly active antiretroviral therapy
Citation
Sharon Appelbaum Nachman, M.D., Jane C. Lindsey, Sc.D., Ph.D., Stephen Ira Pelton, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Ram Yogev, M.D. Lack of improvement in growth in HIV-infected children receiving ritonavir-containing highly active antiretroviral therapy. Archives of Pediatrics and Adolescent Medicine. 2002 May 01; 156(5):497-503.Year
2002
Journal
Archives of Pediatrics and Adolescent Medicine
Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure.
Citation
Mark Mirochnick, M.D., Suzanne Siminski, M.S., M.B.A., Terence Fenton, Ed.D., M. Lugo, John L. Sullivan, M.D. Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure. Journal of Infectious Diseases. 2002 Jul 15; 2(186):181-8.Year
2002
Journal
Journal of Infectious Diseases
Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors
Citation
Ingrid A. Beck, M.S., Madhumita S. Mahalanabis, G. Pepper, A. Wright, Scott Hamilton, R.N., E. Langston, Lisa M. Frenkel, M.D. Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors. Journal of Clinical Microbiology. 2002 Apr 01; 40(4):1413-9. PMID: 11923366; PMCID: PMC140364.Year
2002
Journal
Journal of Clinical Microbiology
Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays
Citation
John L. Schmitz, Ph.D., Thomas Denny, B.S., M.Sc., Ambrosia Garcia-Louzao, M.S., Janet L. Lathey, Ph.D. Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays. Clinical and Diagnostic Laboratory Immunology. 2002 May 01; 9(3):525-9.Year
2002
Journal
Clinical and Diagnostic Laboratory Immunology
Concentration-controlled compared with conventional antiretroviral therapy for HIV infection
Citation
Courtney V. Fletcher, Pharm.D., Peter Anderson, Pharm.D., Thomas N Kakuda, Pharm.D., Timothy Schacker, M.D., W. Keith Henry, M.D., Cynthia R. Gross, Richard Brundage, Pharm.D., Ph.D. Concentration-controlled compared with conventional antiretroviral therapy for HIV infection. AIDS. 2002 Mar 08; 16(4):551-60.Year
2002
Journal
AIDS